Liom
Leo Grünstein is an accomplished entrepreneur and industry leader with significant experience in founding and managing innovative companies. As the Founder and CEO of Liom since December 2017, Grünstein focuses on advancing longevity and preventative medicine through biomarker monitoring. Additionally, Grünstein co-founded Caeli Nova and serves as a Board Member, while also holding the position of Chairman at LG Capital AG, a family office that emphasizes asset management and startup investment. Previously, Grünstein co-founded MoneyPark, a leading Swiss financial intermediary, and has held roles at McKinsey & Company and HSBC in investment banking. Grünstein holds an M.B.A. from Columbia Business School and a Bachelor's degree in Business Administration from the University of St.Gallen.
Liom
The first health wearable monitoring glucose non-invasively. New health insights are unlocked through real time combination of signals. Precision glucose measurements without piercing the skin. This is a world's first. Why glucose? Small irregularities in glucose metabolism compound over time. The progression from healthy to disease is often imperceptible. Awareness is a powerful tool for prevention.